Protein Expression and Genomic Alterations of PMS2 in Urothelial Bladder Cancer

被引：0
|
作者：
Nozad, Sahar
Shiekhmohammed, Mohammed
Kallakury, Bhaskar V. S.
Sheehan, Christine E.
Elvin, Julia A.
Vergilio, Jo-Anne
Suh, James
Ramkissoon, Shakti H.
Ali, Siraj M.
Schrock, Alexa
Pal, Sumanta
Fisher, Hugh A.
Mian, Badar
Nazeer, Tipu
Fabrizio, David
Frampton, Garrett
Connelly, Caitlin
Miller, Vincent
Stephens, Philip
Gay, Laurie M.
Ross, Jeffrey
机构：
[1] Albany Med Coll, Albany, NY 12208 USA
[2] Georgetown Univ Hosp, Washington, DC 20007 USA
[3] Fdn Med, Cambridge, MA USA
来源：
MODERN PATHOLOGY | 2017年 / 30卷
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
994
引用
收藏
页码：246A / 246A
页数：1
相关论文
共 50 条
  • [11] Non-urothelial bladder cancer: Genomic alterations and patient outcomes.
    Anari, Fern
    Miron, Benjamin
    Henson, Donald
    Arguello, David
    Plimack, Elizabeth R.
    Zibelman, Matthew R.
    Ramamurthy, Chethan
    Ghatalia, Pooja
    Heath, Elisabeth I.
    Burgess, Earle Frederick
    Dawson, Nancy Ann
    Vaena, Daniel A.
    Somer, Bradley G.
    Hogan, Thomas F.
    Hauke, Ralph J.
    Aragon-Ching, Jeanny B.
    Geynisman, Daniel M.
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (07)
  • [12] Elevated levels of the mismatch repair protein PMS2 are associated with prostate cancer
    Norris, Alixanna M.
    Woodruff, R. D.
    D'Agostino, Ralph B., Jr.
    Clodfelter, Jill E.
    Scarpinato, Karin Drotschmann
    PROSTATE, 2007, 67 (02): : 214 - 225
  • [13] Frequency and nature of genomic alterations (GA) in ERBB2altered urothelial bladder cancer (UBC)
    Talukder, R.
    Leary, J.
    Enright, T.
    Bakaloudi, D. R.
    Bratslavsky, G.
    Jacob, J. M.
    Spiess, P.
    Li, R.
    Necchi, A.
    Kamat, A.
    Pavlick, D. C.
    Danziger, N. A.
    Huang, R.
    Lin, D. I.
    Ross, J. S.
    Grivas, P.
    ANNALS OF ONCOLOGY, 2023, 34 : S1221 - S1222
  • [14] Clinicopathological, Immunohistochemical, and PMS2 Gene Expression Profiling of Patients with Sporadic Colorectal Cancer
    Mousavi, Maryam
    Goodarzi, Mohammad Taghi
    Kassaee, Seyed Mehrdad
    Heidarloo, Ali Jafari
    Fathi, Mojtaba
    ARCHIVES OF IRANIAN MEDICINE, 2021, 24 (02) : 86 - 93
  • [15] Germline mutations in PMS2 and MLH1 in individuals with solitary loss of PMS2 expression in colorectal carcinomas from the Colon Cancer Family Registry Cohort
    Rosty, Christophe
    Clendenning, Mark
    Walsh, Michael D.
    Eriksen, Stine V.
    Southey, Melissa C.
    Winship, Ingrid M.
    Macrae, Finlay A.
    Boussioutas, Alex
    Poplawski, Nicola K.
    Parry, Susan
    Arnold, Julie
    Young, Joanne P.
    Casey, Graham
    Haile, Robert W.
    Gallinger, Steven
    Le Marchand, Loic
    Newcomb, Polly A.
    Potter, John D.
    DeRycke, Melissa
    Lindor, Noralane M.
    Thibodeau, Stephen N.
    Baron, John A.
    Win, Aung Ko
    Hopper, John L.
    Jenkins, Mark A.
    Buchanan, Daniel D.
    BMJ OPEN, 2016, 6 (02):
  • [16] H. pylori reduces PMS2 and ERCC1 DNA repair protein expression in gastritis and gastric cancer
    Raza, Y.
    Khan, A.
    Ahmed, A.
    Akhter, S.
    Kazmi, S.
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2020, 101 : 150 - 151
  • [17] Biallelic PMS2 mutations and a distinctive childhood cancer syndrome
    Tan, Tiong Yang
    Orme, Lisa M.
    Lynch, Elly
    Croxford, Matthew A.
    Dow, Christopher
    Dewan, Paddy A.
    Lipton, Lara
    JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 2008, 30 (03) : 254 - 257
  • [18] Germline PMS2 mutation screened by mismatch repair protein immunohistochemistry of colorectal cancer in Japan
    Sugano, Kokichi
    Nakajima, Takeshi
    Sekine, Shigeki
    Taniguchi, Hirokazu
    Saito, Shinya
    Takahashi, Masahiro
    Ushiama, Mineko
    Sakamoto, Hiromi
    Yoshida, Teruhiko
    CANCER SCIENCE, 2016, 107 (11) : 1677 - 1686
  • [19] MLH1 and PMS2 protein expression in 103 colorectal carcinomas with MLH1 promoter methylation and without MLH1 or PMS2 germline mutation
    Mahooti, S
    Hampel, H
    LaJeunesse, J
    Sotamaa, K
    de la Chapelle, A
    Frankel, WL
    MODERN PATHOLOGY, 2006, 19 : 113A - 113A
  • [20] PMS2, a potential early biomarker of colon cancer risk
    Holubec, H
    Ramsey, L
    Wilson, M
    Bernstein, C
    Dvorakova, K
    Payne, C
    Garewal, H
    Bernstein, H
    GASTROENTEROLOGY, 2004, 126 (04) : A451 - A451
12345